Park, Kyoung Shin
Ganesh, Alexis B.
Berry, Nathaniel T.
Mobley, Yashonda P.
Karper, William B.
Labban, Jeffrey D.
Wahlheim, Christopher N.
Williams, Tomika M.
Wideman, Laurie
Etnier, Jennifer L.
Funding for this research was provided by:
National Institute on Aging (R01AG058919)
Article History
Received: 27 March 2020
Accepted: 16 April 2020
First Online: 6 June 2020
Ethics approval and consent to participate
: Approval by the Institutional Review Board (IRB) of the University of North Carolina at Greensboro was obtained for the PAAD-2 (IRB number 18–0228). Subsequently, the IRB annually reviews the protocol and reviews modifications as necessary. Participants in this study provide consent prior to the completion of electronic surveys and are provide written informed consent at the first in-person visit at the pre-test. Participants in this study go through a screening test for cognitive normality before the first visit. Therefore, all participants are considered as being capable of ethically and medically consenting for participation on their own behalf. Individuals who do not meet the inclusion criteria for cognitive normality or for depression are encouraged to speak with their personal physician.
: Not applicable.
: The authors declare no commercial, financial or any other conflict of interest in this research.